ARTICLE | Clinical News
Prochymal regulatory update
July 26, 2010 7:00 AM UTC
Health Canada accepted for filing and granted Priority Review to an NDS from Osiris for Prochymal to treat graft-versus-host disease (GvHD). Osiris said the review is expected to take 180 days for the...